
Sign up to save your podcasts
Or


In this episode, we review pneumoconiosis, a group of chronic occupational lung diseases caused by the inhalation and accumulation of mineral dust particles, resulting in persistent pulmonary inflammation and progressive fibrosis. We discuss important occupational exposures, including silica, coal dust, asbestos, and beryllium, along with the classic presentation of progressive exertional dyspnea, persistent dry cough, and chest discomfort, emphasizing the characteristic upper-lobe involvement of silicosis and coal worker's pneumoconiosis versus the lower-lobe predominance of asbestosis. The segment also covers the diagnostic approach, highlighting a detailed occupational history, pulmonary function testing, and characteristic imaging findings such as eggshell calcification in silicosis, pleural plaques in asbestosis, and upper-lobe nodules in coal worker's pneumoconiosis, along with management strategies involving elimination of occupational exposure, smoking cessation, supportive respiratory care, supplemental oxygen, and lung transplantation for advanced disease. We finish with high-yield clinical pearls highlighting the importance of recognizing occupational exposure patterns, understanding the increased risk of tuberculosis in patients with silicosis, identifying the association between asbestos exposure and malignant mesothelioma, and emphasizing prevention and early recognition to reduce irreversible pulmonary damage.
References
In this episode, we review cystic fibrosis (CF), a progressive, autosomal recessive multisystem disorder caused by mutations in the CFTR gene, resulting in impaired chloride and bicarbonate transport and the production of thick, viscous secretions that affect the respiratory, gastrointestinal, endocrine, and reproductive systems. We discuss the underlying genetic mechanisms and classic clinical manifestations, including chronic productive cough, recurrent pulmonary infections, bronchiectasis, pancreatic insufficiency, steatorrhea, failure to thrive, and male infertility, along with important complications such as cystic fibrosis-related diabetes and progressive respiratory failure. The segment also covers the diagnostic approach, emphasizing newborn screening, confirmatory sweat chloride testing, CFTR genetic analysis, and pulmonary function testing, along with treatment strategies involving airway clearance techniques, inhaled antibiotics, mucolytic therapy, pancreatic enzyme replacement, nutritional supplementation, and CFTR modulators such as Trikafta. We finish with high-yield clinical pearls highlighting the importance of recognizing cystic fibrosis as a multisystem disease, understanding the diagnostic significance of elevated sweat chloride levels, preventing recurrent pulmonary infections, and appreciating how early diagnosis and targeted CFTR therapies have significantly improved survival and quality of life.
References
In this episode, we review pulmonary carcinoid tumors, rare, well-differentiated neuroendocrine neoplasms arising from bronchial neuroendocrine cells, with an emphasis on distinguishing typical and atypical carcinoid tumors based on their growth patterns, mitotic activity, and presence of necrosis. We discuss important risk factors, including multiple endocrine neoplasia type 1 (MEN1) syndrome, along with the classic presentation of persistent cough, hemoptysis, recurrent pneumonia, and focal unilateral wheezing, as well as less common manifestations of carcinoid syndrome and ectopic ACTH production. The segment also covers the diagnostic approach, emphasizing chest CT imaging, somatostatin receptor imaging with DOTATATE PET/CT, and tissue diagnosis through bronchoscopy, along with treatment strategies involving complete surgical resection, somatostatin analogs such as octreotide, and targeted therapies for advanced disease. We finish with high-yield clinical pearls highlighting the importance of recognizing central airway obstruction in patients with refractory asthma-like symptoms, understanding the prognostic differences between typical and atypical carcinoids, identifying the potential for life-threatening carcinoid crisis during tumor manipulation, and recognizing surgical resection as the primary curative treatment.
References
In this episode, we review acute bronchiolitis, a common viral lower respiratory tract infection primarily affecting infants and children younger than two years of age, characterized by inflammation, mucus accumulation, and obstruction of the small airways, most frequently caused by respiratory syncytial virus (RSV). We discuss important risk factors for severe illness, including prematurity, young age, congenital heart disease, chronic lung disease, and secondhand smoke exposure, along with the classic progression from rhinorrhea and mild fever to persistent cough, wheezing, tachypnea, nasal flaring, and chest retractions. The segment also covers the diagnostic approach, emphasizing clinical recognition, the limited role of routine chest radiography and viral testing, and identifying signs of respiratory distress, along with treatment strategies focused on supportive care, adequate hydration, supplemental oxygen when indicated, and avoiding unnecessary bronchodilators, corticosteroids, and antibiotics. We finish with high-yield clinical pearls highlighting the importance of recognizing bronchiolitis as a clinical diagnosis, monitoring for respiratory failure, understanding the role of maternal RSV vaccination and long-acting monoclonal antibodies such as nirsevimab in prevention, and educating caregivers about the expected course of illness and warning signs of clinical deterioration.
References
In this episode, we review acute respiratory distress syndrome (ARDS), a life-threatening form of acute hypoxemic respiratory failure characterized by diffuse alveolar inflammation, increased pulmonary capillary permeability, noncardiogenic pulmonary edema, and severely impaired gas exchange. We discuss important underlying causes, including sepsis, pneumonia, aspiration, acute pancreatitis, and major trauma, along with the characteristic progression through the exudative, proliferative, and fibrotic phases and the classic presentation of rapid-onset dyspnea, tachypnea, diffuse crackles, and refractory hypoxemia. The segment also covers the diagnostic approach, emphasizing the Berlin criteria, bilateral pulmonary opacities on chest imaging, exclusion of cardiogenic pulmonary edema, and the PaO₂/FiO₂ ratio for classifying disease severity, along with treatment strategies involving lung-protective mechanical ventilation, low tidal volumes, appropriate PEEP, early prone positioning in severe cases, and conservative fluid management after shock resolution. We finish with high-yield clinical pearls highlighting the importance of recognizing ARDS early, minimizing ventilator-induced lung injury, understanding the mortality benefits of prone positioning, and monitoring for complications such as pneumothorax, ventilator-associated pneumonia, pulmonary fibrosis, and post-intensive care syndrome (PICS).
References
In this episode, we review acute respiratory failure, a potentially life-threatening condition in which the lungs are unable to adequately oxygenate the blood or eliminate carbon dioxide, focusing on the differences between Type I (hypoxemic) and Type II (hypercapnic) respiratory failure. We discuss important underlying causes, including ventilation-perfusion mismatch, pulmonary shunting, alveolar hypoventilation, COPD, pneumonia, pulmonary embolism, and neuromuscular disorders, along with the classic presentation of dyspnea, tachypnea, hypoxemia, accessory muscle use, cyanosis, and altered mental status. The segment also covers the diagnostic approach, emphasizing pulse oximetry, arterial blood gas analysis, chest radiography, and identifying the underlying cause of respiratory compromise, along with treatment strategies involving supplemental oxygen, high-flow nasal cannula, noninvasive positive pressure ventilation, and endotracheal intubation with mechanical ventilation when indicated. We finish with high-yield clinical pearls highlighting the importance of distinguishing hypoxemic from hypercapnic respiratory failure, recognizing the critical role of arterial blood gases in diagnosis, identifying patients requiring ventilatory support, and preventing serious complications such as respiratory arrest, multiorgan dysfunction, and death.
References
In this episode, we review respiratory syncytial virus (RSV), a common viral respiratory infection and a leading cause of bronchiolitis in infants and children younger than two years of age, characterized by inflammation and obstruction of the small airways. We discuss important risk factors for severe illness, including prematurity, congenital heart disease, immunocompromised states, and young age, along with the classic presentation of rhinorrhea, nasal congestion, cough, wheezing, fever, poor feeding, and increased work of breathing. The segment also covers the diagnostic approach, emphasizing clinical recognition, selective use of viral testing, and identifying signs of respiratory distress such as tachypnea, nasal flaring, and chest retractions, along with treatment strategies involving supportive care, nasal suctioning, hydration, supplemental oxygen, and respiratory support when indicated. We finish with high-yield clinical pearls highlighting the importance of understanding how RSV causes syncytia formation and bronchiolar obstruction, recognizing infants at increased risk for apnea and respiratory failure, monitoring for clinical deterioration, and preventing severe infection through maternal RSV vaccination and infant monoclonal antibody prophylaxis.
References
In this episode, we review pneumothorax, a potentially life-threatening pulmonary condition characterized by the accumulation of air within the pleural space, resulting in partial or complete lung collapse. We discuss the differences between primary spontaneous, secondary spontaneous, traumatic, and tension pneumothorax, along with important risk factors such as smoking, underlying pulmonary disease, chest trauma, and a tall, thin body habitus, and the classic presentation of sudden-onset pleuritic chest pain, dyspnea, decreased breath sounds, and hyperresonance to percussion. The segment also covers the diagnostic approach, emphasizing chest radiography, bedside ultrasonography demonstrating absent lung sliding, and CT imaging when indicated, along with treatment strategies involving observation, supplemental oxygen, chest tube placement, and emergent needle decompression for tension pneumothorax. We finish with high-yield clinical pearls highlighting the importance of recognizing tension pneumothorax as an immediate life-threatening emergency, identifying signs of hemodynamic compromise, understanding when urgent decompression is necessary, and preventing complications such as respiratory failure, cardiac arrest, and recurrent pneumothorax.
References
In this episode, we review sleep apnea, a common sleep-related breathing disorder characterized by repeated episodes of apnea and hypopnea, focusing on the differences between obstructive sleep apnea (OSA) and central sleep apnea (CSA). We discuss important risk factors, including obesity, increasing age, male sex, craniofacial abnormalities, cardiovascular disease, and opioid use, along with the classic presentation of loud snoring, witnessed apneic episodes, nocturnal gasping or choking, excessive daytime sleepiness, morning headaches, and impaired concentration. The segment also covers the diagnostic approach, emphasizing screening tools such as the STOP-BANG questionnaire and Epworth Sleepiness Scale, the gold standard of polysomnography, and the apnea-hypopnea index (AHI) for determining disease severity, along with treatment strategies involving continuous positive airway pressure (CPAP), alternative positive airway pressure therapies, oral appliances, and selected surgical interventions. We finish with high-yield clinical pearls highlighting the importance of distinguishing obstructive from central sleep apnea, recognizing the importance of CPAP adherence, and preventing long-term complications such as hypertension, cardiac arrhythmias, heart failure, stroke, cognitive impairment, and motor vehicle accidents.
References
American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017 Mar 15;13(3):479-504. doi: 10.5664/jcsm.6506. PMID: 28162150; PMCID: PMC5337595.
In this episode, we review acute bronchitis, a common respiratory condition characterized by inflammation of the bronchi and increased mucus production, most frequently caused by viral infections. We discuss important risk factors, including smoking, asthma, environmental irritants, and exposure to respiratory infections, along with the classic presentation of persistent cough lasting 1–3 weeks, sputum production, wheezing, fatigue, and occasional fever. The segment also covers the diagnostic approach, emphasizing clinical evaluation, distinguishing acute bronchitis from pneumonia, and the role of chest radiography when abnormal vital signs or concerning examination findings are present, along with treatment strategies involving supportive care, cough suppressants, expectorants, and patient reassurance. We finish with high-yield clinical pearls highlighting the importance of recognizing that approximately 90% of cases are viral, avoiding unnecessary antibiotic prescriptions, setting realistic expectations for cough duration, and identifying warning signs that warrant further evaluation for pneumonia or other serious respiratory conditions.
References
From the publisher's feed